##gff-version 3
##sequence-region Q9H093 1 628
Q9H093	UniProtKB	Chain	1	628	.	.	.	ID=PRO_0000247756;Note=NUAK family SNF1-like kinase 2	
Q9H093	UniProtKB	Domain	53	303	.	.	.	Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q9H093	UniProtKB	Nucleotide binding	59	67	.	.	.	Note=ATP;Ontology_term=ECO:0000250,ECO:0000255;evidence=ECO:0000250|UniProtKB:O60285,ECO:0000255|PROSITE-ProRule:PRU00159	
Q9H093	UniProtKB	Active site	175	175	.	.	.	Note=Proton acceptor;Ontology_term=ECO:0000250,ECO:0000255,ECO:0000255;evidence=ECO:0000250|UniProtKB:O60285,ECO:0000255|PROSITE-ProRule:PRU00159,ECO:0000255|PROSITE-ProRule:PRU10027	
Q9H093	UniProtKB	Binding site	81	81	.	.	.	Note=ATP;Ontology_term=ECO:0000255,ECO:0000269;evidence=ECO:0000255|PROSITE-ProRule:PRU00159,ECO:0000269|PubMed:15345718;Dbxref=PMID:15345718	
Q9H093	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22814378;Dbxref=PMID:22814378	
Q9H093	UniProtKB	Modified residue	208	208	.	.	.	Note=Phosphothreonine%3B by LKB1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14976552;Dbxref=PMID:14976552	
Q9H093	UniProtKB	Modified residue	435	435	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19369195;Dbxref=PMID:19369195	
Q9H093	UniProtKB	Modified residue	523	523	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19369195;Dbxref=PMID:19369195	
Q9H093	UniProtKB	Modified residue	544	544	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19369195;Dbxref=PMID:19369195	
Q9H093	UniProtKB	Modified residue	547	547	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19369195;Dbxref=PMID:19369195	
Q9H093	UniProtKB	Modified residue	573	573	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8BZN4	
Q9H093	UniProtKB	Natural variant	309	309	.	.	.	ID=VAR_040964;Note=T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs55745939,PMID:17344846	
Q9H093	UniProtKB	Natural variant	341	341	.	.	.	ID=VAR_040965;Note=R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs35208615,PMID:17344846	
Q9H093	UniProtKB	Natural variant	503	503	.	.	.	ID=VAR_040966;Note=In an ovarian Endometrioid carcinoma sample%3B somatic mutation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=PMID:17344846	
Q9H093	UniProtKB	Natural variant	516	516	.	.	.	ID=VAR_040967;Note=A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs35070935,PMID:17344846	
Q9H093	UniProtKB	Natural variant	541	541	.	.	.	ID=VAR_040968;Note=In a breast pleomorphic lobular carcinoma sample%3B somatic mutation. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=PMID:17344846	
Q9H093	UniProtKB	Mutagenesis	81	81	.	.	.	Note=Loss of autophosphorylation%2C kinase activity and of anti-apoptotic activity. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15345718;Dbxref=PMID:15345718	
Q9H093	UniProtKB	Mutagenesis	208	208	.	.	.	Note=Prevents phosphorylation and activation by STK11/LKB1 complex. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14976552;Dbxref=PMID:14976552	
